<p><strong>Adults (16 Years and older)</strong>: The recommended starting dosage for monotherapy or adjunctive therapy is 50 mg twice daily (100 mg per day).<br />
<br />
Based on individual patient tolerability and therapeutic response, the dosage may be adjusted down to 25 mg twice daily (50 mg per day) or up to 100 mg twice daily (200 mg per day).<br />
<br />
<strong>Pediatric Patients (4 Years to less than 16 Years)</strong>: The recommended dosage is based on body weight and is administered orally twice daily<br />
<br />
<strong>Injection</strong>: for intravenous and adult use only when oral administration is temporarily not feasible; dosing is the same as oral regimen.</p>

<p>&nbsp;</p>

<p><strong>Administration</strong></p>

<p>Brivaracetam injection should be administered intravenously over 2 to 15 minutes. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Product with particulate matter or discoloration should not be used. Brivaracetam injection is for single dose only.</p>